Next report date
Report period
Q1 2024
EPS estimate
−0.43USD
Revenue estimate
4.40 MUSD
−86.88 MUSD
14.92 MUSD
19.35 M
Om Carisma Therapeutics, Inc.
Sektor
Bransch
VD
Steven Kelly
Webbplats
Huvudkvarter
Philadelphia
Employees (FY)
107
Grundat
2016
FIGI
BBG001J2N453
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
